Skip to main content

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Psychopharmacology

Medication in hand
Navigating the A to Z of Schizophrenia, Part 3: Novel Treatment Mechanisms

Welcome to Schizophrenia Knowledge Base

This website is intended for healthcare professionals in the United States.

Yes, I am a US healthcare professional
No, I am not a US healthcare professional
Provider with medication
CME: Exploring Treatment Advances for Schizophrenia: Focus on the Patient Experience
Neuron
CME: Addressing the Core Issue: Presynaptic Modulation in Schizophrenia Using a Novel Class of Medication
Patient and provider
CME: How to Make Appropriate Treatment Decisions for Patients With Schizophrenia
LAI
CME: Expert Panel: Optimizing Use of Long-Acting Injectable Medications in People With Schizophrenia in Community Settings
Patient medication
Xanomeline-Trospium Chloride in Schizophrenia: Phase 3 Trial
Dr Meyer
Tailoring Treatment to Patient Goals and Providing the Clozapine Option as Standard of Care With Dr Jonathan M. Meyer
Providers looking at images
How Muscarinic Stimulation Works in Psychosis
brain waves
Questions on Novel Dopaminergic Agents For Schizophrenia

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3
© 2025 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy